BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16814095)

  • 1. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell.
    Robertson RP; Harmon JS
    Free Radic Biol Med; 2006 Jul; 41(2):177-84. PubMed ID: 16814095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of oxidative stress by adenoviral overexpression of glutathione-related enzymes in pancreatic islets.
    Robertson RP; Tanaka Y; Takahashi H; Tran PO; Harmon JS
    Ann N Y Acad Sci; 2005 Jun; 1043():513-20. PubMed ID: 16037273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2002 Jul; 3(4):86-108. PubMed ID: 12110767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy.
    Robertson RP
    Discov Med; 2010 Feb; 9(45):132-7. PubMed ID: 20193639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.
    Robertson RP; Harmon J; Tran PO; Tanaka Y; Takahashi H
    Diabetes; 2003 Mar; 52(3):581-7. PubMed ID: 12606496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
    Kaneto H; Nakatani Y; Kawamori D; Miyatsuka T; Matsuoka TA; Matsuhisa M; Yamasaki Y
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1595-608. PubMed ID: 15878838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
    Király MA; Bates HE; Yue JT; Goche-Montes D; Fediuc S; Park E; Matthews SG; Vranic M; Riddell MC
    Metabolism; 2007 Jun; 56(6):732-44. PubMed ID: 17512304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring a functional beta-cell mass in diabetes.
    Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes mellitus as a conformational disease.
    Hayden MR; Tyagi SC; Kerklo MM; Nicolls MR
    JOP; 2005 Jul; 6(4):287-302. PubMed ID: 16006679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose regulation of β-cell stress in type 2 diabetes.
    Leibowitz G; Bachar E; Shaked M; Sinai A; Ketzinel-Gilad M; Cerasi E; Kaiser N
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():66-75. PubMed ID: 21029302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes.
    Jonas JC; Bensellam M; Duprez J; Elouil H; Guiot Y; Pascal SM
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():65-81. PubMed ID: 19817790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of the diabetic status on the oxidant/antioxidant balance.
    Bonnefont-Rousselot D; Bastard JP; Jaudon MC; Delattre J
    Diabetes Metab; 2000 May; 26(3):163-76. PubMed ID: 10880889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
    Kim MJ; Kim HK
    Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in pancreatic beta-cell dysfunction.
    Kajimoto Y; Kaneto H
    Ann N Y Acad Sci; 2004 Apr; 1011():168-76. PubMed ID: 15126294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cAMP level attenuates 2-deoxy-d-ribose-induced oxidative damage in pancreatic beta-cells.
    Koh G; Suh KS; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS
    Arch Biochem Biophys; 2005 Jun; 438(1):70-9. PubMed ID: 15910737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.